Bionano Genomics, Inc.
BNGO
$1.85
$0.042.21%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.42% | 4.27% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.42% | 4.27% | |||
| Cost of Revenue | 22.76% | -7.47% | |||
| Gross Profit | -3.08% | 18.35% | |||
| SG&A Expenses | 8.60% | -7.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.44% | -2.61% | |||
| Operating Income | -9.46% | 7.86% | |||
| Income Before Tax | -23.98% | -121.23% | |||
| Income Tax Expenses | 40.00% | 42.86% | |||
| Earnings from Continuing Operations | -24.00% | -121.05% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -24.00% | -121.05% | |||
| EBIT | -9.46% | 7.86% | |||
| EBITDA | -13.82% | 10.22% | |||
| EPS Basic | 20.06% | -73.07% | |||
| Normalized Basic EPS | 20.08% | -73.20% | |||
| EPS Diluted | 20.06% | -73.07% | |||
| Normalized Diluted EPS | 20.08% | -73.20% | |||
| Average Basic Shares Outstanding | 55.13% | 27.73% | |||
| Average Diluted Shares Outstanding | 55.13% | 27.73% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||